Owlet (OWLT) Cash from Financing Activities (2020 - 2026)

Owlet's (OWLT) quarterly Cash from Financing Activities came in at $5.5 million in Q1 2026, up 171.2% year-on-year from $2.0 million in Q1 2025, and down 69.47% on a QoQ basis from $17.9 million in Q4 2025.

Owlet (OWLT) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Owlet (OWLT) has 7 years of Cash from Financing Activities data on file, last reported at $5.5 million in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 171.2% year-over-year to $5.5 million in Q1 2026; TTM through Mar 2026 was $35.6 million, a 177.29% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, up 100.17% from the prior year.
  • Cash from Financing Activities for Q1 2026 stood at $5.5 million, down from $17.9 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for OWLT reached as high as $22.9 million in Q1 2023 and fell as low as -$4.4 million in Q3 2023.
  • Historically, Cash from Financing Activities has averaged $4.8 million across 5 years, with a median of $3.0 million in 2023.
  • Across the five-year window, Cash from Financing Activities sank 321.79% in 2023 and surged 2033.42% in 2025, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$2.0 million in 2022, then surged by 253.22% to $3.0 million in 2023, then plunged by 236.24% to -$4.1 million in 2024, then soared by 538.21% to $17.9 million in 2025, then sank by 69.47% to $5.5 million in 2026.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $5.5 million in Q1 2026, $17.9 million in Q4 2025, and $4.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 181.32 Bn 174.03 Bn 6.27 Bn 17.31 Bn
2 Stryker 128.59 Bn 125.71 Bn 3.81 Bn -1.51 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 67.77 Bn 66.32 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 48.13 Bn 44.46 Bn 1.29 Bn -451.20 Mn
6 GE HealthCare Technologies 28.44 Bn 26.15 Bn 1.98 Bn 21.00 Mn
7 Dexcom 28.41 Bn 27.29 Bn 750.30 Mn -25.00 Mn
8 Smith & Nephew 26.77 Bn 26.20 Bn - -
9 Koninklijke Philips 25.24 Bn 22.11 Bn 2.07 Bn -26.93 Mn
10 Owlet 148.59 Mn 107.59 Mn 12.24 Mn 5.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.46 Mn
Mar 31, 2026 5.46 Mn
Dec 31, 2025 17.89 Mn
Dec 31, 2025 17.89 Mn
Sep 30, 2025 4.36 Mn
Sep 30, 2025 4.36 Mn
Jun 30, 2025 7.85 Mn
Jun 30, 2025 7.85 Mn
Mar 31, 2025 2.01 Mn
Mar 31, 2025 2.01 Mn
Dec 31, 2024 -4.08 Mn
Dec 31, 2024 -4.08 Mn
Sep 30, 2024 14.53 Mn
Sep 30, 2024 14.53 Mn
Jun 30, 2024 368,000.00
Jun 30, 2024 368,000.00
Mar 31, 2024 5.23 Mn
Mar 31, 2024 5.23 Mn
Dec 31, 2023 3.00 Mn
Dec 31, 2023 3.00 Mn